Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219604 · ClinicalTrials.gov registry record · Phase 4
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
A Phase 4 study, sponsored by Dent Neuroscience Research Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT05219604 is a Phase 4 study that was terminated before completion, run by Dent Neuroscience Research Center. The registered enrollment target is 3 participants.
The verdict
NCT05219604, a Phase 4 study, was terminated before completion, sponsored by Dent Neuroscience Research Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study seeks to explore the magnitude and duration of central nervous system effects and pharmacokinetics after intravenous infusion of diphenhydramine.
Interventions
- DRUG DiphenhydrAMINE Injectable Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2022-10-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05219604
The ClinicalTrials.gov registry entry for NCT05219604 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dent Neuroscience Research Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DiphenhydrAMINE Injectable Solution is the first listed.
NCT05219604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05219604 about?
NCT05219604 is a clinical study titled "Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling". This study seeks to explore the magnitude and duration of central nervous system effects and pharmacokinetics after intravenous infusion of diphenhydramine.
What is the current status of trial NCT05219604?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2022-03-15. Estimated completion is 2022-10-04.
What interventions are being tested in trial NCT05219604?
The interventions under investigation include: DiphenhydrAMINE Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05219604?
This trial is sponsored by Dent Neuroscience Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.